Global Colloids (Blood Plasma) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Colloids (Blood Plasma) market size was valued at US$ 398 million in 2024 and is forecast to a readjusted size of USD 335 million by 2031 with a CAGR of -2.4% during review period.
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
This report is a detailed and comprehensive analysis for global Colloids (Blood Plasma) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Colloids (Blood Plasma) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Colloids (Blood Plasma) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Colloids (Blood Plasma) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Colloids (Blood Plasma) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colloids (Blood Plasma)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colloids (Blood Plasma) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Colloids (Blood Plasma) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Market segment by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
Major players covered
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Colloids (Blood Plasma) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Colloids (Blood Plasma), with price, sales quantity, revenue, and global market share of Colloids (Blood Plasma) from 2020 to 2025.
Chapter 3, the Colloids (Blood Plasma) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Colloids (Blood Plasma) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Colloids (Blood Plasma) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Colloids (Blood Plasma).
Chapter 14 and 15, to describe Colloids (Blood Plasma) sales channel, distributors, customers, research findings and conclusion.
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
North America is the largest Colloids (Blood Plasma) market with about 33% market share. Europe is follower, accounting for about 28% market share.
The key players are CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, B. Braun Medical, Fresenius Kabi, HOSPIRA, Axa parenterals, Fresenius Kabi(China), CR Double-Crane, Kelun Group, Shandong Qidu Pharmaceutical, Shandong Hualu Pharmaceutical, Minsheng Pharma, Kanglepharm etc. Top 3 companies occupied about 46% market share.
This report is a detailed and comprehensive analysis for global Colloids (Blood Plasma) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Colloids (Blood Plasma) market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Colloids (Blood Plasma) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Colloids (Blood Plasma) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2020-2031
Global Colloids (Blood Plasma) market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colloids (Blood Plasma)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colloids (Blood Plasma) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Baxter, Grifols, Octapharma, Kedrion, Shanghai Raas, CTBB, Hualan Bio, Rongsheng Pharmaceutical, Boya Rongsheng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Colloids (Blood Plasma) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Market segment by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
Major players covered
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi (China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Colloids (Blood Plasma) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Colloids (Blood Plasma), with price, sales quantity, revenue, and global market share of Colloids (Blood Plasma) from 2020 to 2025.
Chapter 3, the Colloids (Blood Plasma) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Colloids (Blood Plasma) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Colloids (Blood Plasma) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Colloids (Blood Plasma).
Chapter 14 and 15, to describe Colloids (Blood Plasma) sales channel, distributors, customers, research findings and conclusion.
Table of Contents
154 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Colloids (Blood Plasma) by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
